Stocks and Investing
Stocks and Investing
Tue, February 8, 2022
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
[ Tue, Feb 08th 2022
] - WOPRAI
Fatima Boolani Maintained (VRNS) at Strong Buy with Decreased Target to $55 on, Feb 8th, 2022
Fatima Boolani of UBS, Maintained "Varonis Systems, Inc." (VRNS) at Strong Buy with Decreased Target from $74 to $55 on, Feb 8th, 2022.
Fatima has made no other calls on VRNS in the last 4 months.
There is 1 other peer that has a rating on VRNS. Out of the 1 peers that are also analyzing VRNS, 0 agree with Fatima's Rating of Hold.
This is the rating of the analyst that currently disagrees with Fatima
- Matthew Hedberg of "RBC Capital" Maintained at Buy with Increased Target to $82 on, Monday, October 25th, 2021
Contributing Sources